The Role of Oxidants in Percutaneous Coronary Intervention-Induced Endothelial Dysfunction: Can We Harness Redox Signaling to Improve Clinical Outcomes?
- 3 May 2023
- journal article
- research article
- Published by SAGE Publications in Antioxidants & Redox Signaling
- Vol. 38 (13-15) , 1022-1040
Abstract
Significance: Coronary artery disease (CAD) is commonly treated using percutaneous coronary interventions (PCI). However, PCI with stent placement damages the endothelium, and failure to restore endothelial function may result in PCI failure with poor patient outcomes. Recent Advances: Oxidative signaling is central to maintaining endothelial function. Potentiation of oxidant production, as observed post-PCI, results in endothelial dysfunction (ED). This review delves into our current understanding of the physiological role that endothelial-derived oxidants play within the vasculature and the effects of altered redox signaling during dysfunction. We then examine the impact of PCI and intracoronary stent placement on oxidant production in the endothelium, which can culminate in stent failure. Finally, we explore how recent advances in PCI and stent technologies aim to mitigate PCI-induced oxidative damage and improve clinical outcomes. Critical Issues: Current PCI technologies exacerbate cellular oxidant levels, driving ED. If left uncontrolled, oxidative signaling leads to increased intravascular inflammation, restenosis, and neoatherosclerosis. Future Directions: Through the development of novel biomaterials and therapeutics, we can limit PCI-induced oxidant production, allowing for the restoration of a healthy endothelium and preventing CAD recurrence.Keywords
This publication has 151 references indexed in Scilit:
- Caveolin-1 Inhibits Expression of Antioxidant Enzymes through Direct Interaction with Nuclear Erythroid 2 p45-related Factor-2 (Nrf2)Journal of Biological Chemistry, 2012
- Single atom substitution in mouse protein kinase G eliminates oxidant sensing to cause hypertensionNature Medicine, 2012
- The Pathology of Neoatherosclerosis in Human Coronary ImplantsJACC, 2011
- Endothelial nitric oxide synthase negatively regulates hydrogen peroxide-stimulated AMP-activated protein kinase in endothelial cellsProceedings of the National Academy of Sciences, 2009
- Inhibition of thioredoxin reductase 1 by caveolin 1 promotes stress‐induced premature senescenceEMBO Reports, 2009
- Nitric oxide‐induced biphasic mechanism of vascular relaxation via dephosphorylation of CPI‐17 and MYPT1The Journal of Physiology, 2009
- Genetic Evidence Supporting a Critical Role of Endothelial Caveolin-1 during the Progression of AtherosclerosisCell Metabolism, 2009
- Glutathione: Overview of its protective roles, measurement, and biosynthesisMolecular Aspects of Medicine, 2009
- Outcomes Following Coronary Stenting in the Era of Bare-Metal vs the Era of Drug-Eluting StentsJAMA, 2008
- Beneficial effect of a short-acting NO donor for the prevention of neointimal hyperplasiaFree Radical Biology and Medicine, 2008